NL-OMON34238已完成3 期
An open-label extension study of CACZ885H2357E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2357E2
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Successful completion of preceding study CACZ885H2357E1 or 9 flares during that study.
排除标准
- •Pregnancy and lactation.
- •No contraception or insufficiently safe contraception method (women of childbearing potential)
研究者
相似试验
进行中（未招募）
1 期
An open-label extension study of CACZ885H2357E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2357E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-020060-38-NLovartis Pharma Services AG
进行中（未招募）
不适用
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-019559-23-SEovartis Pharma Services AG200
进行中（未招募）
不适用
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2Treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffectiveMedDRA version: 12.1Level: LLTClassification code 10018627Term: GoutEUCTR2010-019559-23-DEovartis Pharma Services AG200
进行中（未招募）
不适用
/AEUCTR2010-019559-23-LVovartis Pharma Services AG200
进行中（未招募）
不适用
An open-label extension study of CACZ885H2356E1 on the treatment and prevention of gout flares in patients with frequent flares for whom NSAIDs and/ or colchicine are contraindicated, not tolerated or ineffective - H2356E2EUCTR2010-019559-23-LTovartis Pharma Services AG200